Kluger H - Search Results

1

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.

Ott PA, Hamid O, Pavlick AC, Kluger H, Kim KB, Boasberg PD, Simantov R, Crowley E, Green JA, Hawthorne T, Davis TA, Sznol M, Hwu P. Ott PA, et al. Among authors: kluger h. J Clin Oncol. 2014 Nov 10;32(32):3659-66. doi: 10.1200/JCO.2013.54.8115. Epub 2014 Sep 29. J Clin Oncol. 2014. PMID: 25267741 Free PMC article. Clinical Trial.

2

Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.

McCarthy MM, Sznol M, DiVito KA, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Clin Cancer Res. 2005 Jul 15;11(14):5188-94. doi: 10.1158/1078-0432.CCR-05-0158. Clin Cancer Res. 2005. PMID: 16033835

3

Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.

McCarthy MM, DiVito KA, Sznol M, Kovacs D, Halaban R, Berger AJ, Flaherty KT, Camp RL, Lazova R, Rimm DL, Kluger HM. McCarthy MM, et al. Clin Cancer Res. 2006 Jun 15;12(12):3856-63. doi: 10.1158/1078-0432.CCR-06-0190. Clin Cancer Res. 2006. PMID: 16778114 Free PMC article.

4

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.

Kluger HM, McCarthy MM, Alvero AB, Sznol M, Ariyan S, Camp RL, Rimm DL, Mor G. Kluger HM, et al. J Transl Med. 2007 Jan 26;5:6. doi: 10.1186/1479-5876-5-6. J Transl Med. 2007. PMID: 17257402 Free PMC article.

5

HSP90 as a marker of progression in melanoma.

McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, Rimm DL, Kluger HM. McCarthy MM, et al. Among authors: kluger y, kluger hm. Ann Oncol. 2008 Mar;19(3):590-4. doi: 10.1093/annonc/mdm545. Epub 2007 Nov 23. Ann Oncol. 2008. PMID: 18037622 Free article.

6

Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer.

Acquavella N, Kluger H, Rhee J, Farber L, Tara H, Ariyan S, Narayan D, Kelly W, Sznol M. Acquavella N, et al. Among authors: kluger h. J Immunother. 2008 Jul-Aug;31(6):569-76. doi: 10.1097/CJI.0b013e318177a4ba. J Immunother. 2008. PMID: 18528297

7

Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells.

Kluger HM, Siddiqui SF, Angeletti C, Sznol M, Kelly WK, Molinaro AM, Camp RL. Kluger HM, et al. Lab Invest. 2008 Sep;88(9):962-72. doi: 10.1038/labinvest.2008.65. Epub 2008 Jul 14. Lab Invest. 2008. PMID: 18626467 Free article.

8

Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.

Jilaveanu L, Zito C, Lee SJ, Nathanson KL, Camp RL, Rimm DL, Flaherty KT, Kluger HM. Jilaveanu L, et al. Clin Cancer Res. 2009 Feb 1;15(3):1076-85. doi: 10.1158/1078-0432.CCR-08-2280. Clin Cancer Res. 2009. PMID: 19188183 Free PMC article. Clinical Trial.

9

C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.

Jilaveanu LB, Zito CR, Aziz SA, Conrad PJ, Schmitz JC, Sznol M, Camp RL, Rimm DL, Kluger HM. Jilaveanu LB, et al. Clin Cancer Res. 2009 Sep 15;15(18):5704-13. doi: 10.1158/1078-0432.CCR-09-0198. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737955 Free PMC article.

10

Melanoma prognostic model using tissue microarrays and genetic algorithms.

Gould Rothberg BE, Berger AJ, Molinaro AM, Subtil A, Krauthammer MO, Camp RL, Bradley WR, Ariyan S, Kluger HM, Rimm DL. Gould Rothberg BE, et al. J Clin Oncol. 2009 Dec 1;27(34):5772-80. doi: 10.1200/JCO.2009.22.8239. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters